ozanimod

This page shows the latest ozanimod news and features for those working in and with pharma, biotech and healthcare.

BMS and bluebird bio file ide-cel CAR-T for multiple myeloma in US

BMS has already claimed approval for multiple sclerosis therapy Zeposia (ozanimod), the first of the three, while the second – lisocabtagene maraleucel or liso-cel for lymphoma – is under regulatory review.

Latest news

BMS suspends new clinical trials as COVID-19 cases rise in US

That includes an FDA decision on multiple sclerosis therapy ozanimod, which was due yesterday, and a verdict due by 4 April for Reblozyl (luspatercept) as a second-line therapy for anaemia
J&J aims for US approval of MS drug ponesimod

Bristol-Myers Squibb may also possess a potential rival, as it is due for an FDA decision on its MS drug ozanimod soon, following a series of delays due to the
Celgene drugs drive BMS to a buoyant Q4, but Opdivo stalls

BMS share price up by 3% on the back of results
Biogen’s R&D chief Ehlers heads for the exit

Biogen is heavily reliant on its wider MS portfolio, and a slew of newly launched or anticipated rival therapies like Novartis’ Mayzent (ozanimod) and Roche’s Ocrevus (ocelizumab) are already threatening
J&J’s ponesimiod tops Aubagio in head-to-head MS trial

Also coming through the pipeline is Biogen’s Tecfidera follow-up diroximel fumarate (BIIB098), Novartis’ new antibody ofatumumab, and Celgene’s S1P receptor modulator ozanimod that is due for regulatory decision

More from news
Approximately 3 fully matching, plus 20 partially matching documents found.

Latest Intelligence

20 for 2020 – Five pharma companies to watch

treatment ozanimod and myelodysplastic syndromes/beta thalassaemia candidate luspatercept – to deliver on their potential.
Pharma deals in July 2015

Celgene believes Receptos's ozanimod in phase III for ulcerative colitis could reach peak sales of $4bn to $6bn per year. ... Receptos / Celgene. Company acquisition. Ozanimod in Phase 3 for auto-immune disease.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Account Director: £Competitive Salary

Senior External Communications Lead: £Competitive Salary

Account Manager: £Competitive Salary

Brand Manager - Medium Global Pharma Company: £Competitive Financial Package

Senior Medical Writer or Lead Medical Writer: £Competitive Salary

Group Director of Medical Affairs and Scientific Strategy, Medic...: Substantial six figure package

Account Manager (PR): Great Benefits

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Account Director – UK Office: Excellent salary and benefits

Senior Account Manager: Salary TBC

PMHub

Add my company

Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?: Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma funding and M&A in 2020: Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?: Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...